ZY-444

CAS No. 1802650-31-2

ZY-444( —— )

Catalog No. M35658 CAS No. 1802650-31-2

ZY-444 is a small molecule inhibiting the progression of breast cancer by targeting pyruvate carboxylase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 134 Get Quote
5MG 202 Get Quote
10MG 297 Get Quote
25MG 609 Get Quote
50MG 916 Get Quote
100MG 1638 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ZY-444
  • Note
    Research use only, not for human use.
  • Brief Description
    ZY-444 is a small molecule inhibiting the progression of breast cancer by targeting pyruvate carboxylase.
  • Description
    ZY-444 is a small molecule that suppresses breast cancer progression by targeting pyruvate carboxylase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1802650-31-2
  • Formula Weight
    444.59
  • Molecular Formula
    C26H28N4OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (224.93 mM; Ultrasonic )
  • SMILES
    N=1C=CC(=NC1NCC(C)C)NCC=2SC(=CC2)C=3C=CC(OCC=4C=CC=CC4)=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lin Q, et al. Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression. Adv Sci (Weinh). 2020 Mar 12;7(9):1903483.?
molnova catalog
related products
  • Hexadecan-3-ol

    Hexadecan-3-ol (3-Hexadecanol) is an oxidation intermediate and a surfactant that can be used to synthesize other compounds.

  • Tau-aggregation and ...

    Tau-aggregation and neuroinflammation-IN-1 is a potent inhibitor of tau protein aggregates, showing significant inhibitory activity against AcPHF6 and full-length tau protein aggregates.

  • Notoginsenoside L13

    Reference standards.